Pitcairn CO Viatris Inc Transaction History

Pitcairn CO

$1.67 Billion
Q3 2024

A detailed history of Pitcairn CO transactions in Viatris Inc stock. As of the latest transaction made, Pitcairn CO holds 33,198 shares of VTRS stock, worth $431,574. This represents 0.02% of its overall portfolio holdings.

Number of Shares

33,198

Previous 51,670 35.75%

Holding current value

$431,574

Previous $549,000 29.87%

% of portfolio

0.02%

Previous 0.03%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$10.32 - $12.13 $190,631 - $224,065	-18,472 Reduced 35.75%	33,198 $385,000
Q2 2024 Aug 13, 2024	SELL	$10.05 - $12.02 $1.47 Million - $1.75 Million	-145,813 Reduced 73.84%	51,670 $549,000
Q1 2024 May 13, 2024	SELL	$11.27 - $13.53 $557,887 - $669,762	-49,502 Reduced 20.04%	197,483 $2.36 Million
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $678,920 - $839,941	-77,414 Reduced 23.86%	246,985 $2.67 Million
Q3 2023 Nov 13, 2023	BUY	$9.59 - $11.35 $32,606 - $38,590	3,400 Added 1.06%	324,399 $3.2 Million
Q2 2023 Aug 11, 2023	BUY	$9.02 - $10.29 $923,133 - $1.05 Million	102,343 Added 46.81%	320,999 $3.2 Million
Q1 2023 May 05, 2023	BUY	$9.2 - $12.26 $940,405 - $1.25 Million	102,218 Added 87.79%	218,656 $2.1 Million
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $828,356 - $1.1 Million	94,995 Added 443.01%	116,438 $1.3 Million
Q3 2022 Nov 10, 2022	SELL	$8.48 - $11.13 $14,967 - $19,644	-1,765 Reduced 7.61%	21,443 $183,000
Q2 2022 Aug 12, 2022	BUY	$9.95 - $12.27 $57,978 - $71,497	5,827 Added 33.53%	23,208 $243,000
Q1 2022 May 12, 2022	BUY	$9.81 - $15.4 $170,507 - $267,667	17,381 New	17,381 $189,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account